Efficacy and Safety of Augmentation of Creatine for the Patients With Major Depressive Disorder
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Creatine monohydrate (Primary) ; Escitalopram
- Indications Major depressive disorder
- Focus Therapeutic Use
- 05 Jul 2017 Biomarkers information updated
- 30 Aug 2012 New trial record
- 01 Aug 2012 Results in women (n=52) published in the American Journal of Psychiatry.